# Direct visualization of chimeric antigen receptors on primary human T cells using dSTORM super-resolution microscopy

**Authors:** Leon Gehrke, Nicole Seifert, Peter Spieler, Christina Verbruggen, Rick Seifert, Fabio Toppeta, Maximilian Krick, Sören Doose, Hermann Einsele, Michael Hudecek, Markus Sauer, Thomas Nerreter

PMC · DOI: 10.3389/fimmu.2025.1632823 · Frontiers in Immunology · 2025-08-01

## TL;DR

Researchers used advanced microscopy to directly visualize CARs on human T cells, offering new insights into their surface expression and potential for improving CAR-T cell therapy.

## Contribution

A novel, tag-free method for direct CAR labeling and visualization using dSTORM super-resolution microscopy is introduced.

## Key findings

- CAR surface expression targeting SLAMF7, BCMA, and CD19 was detected with minimal background.
- T cell subtype, donor material, and CAR construct influence CAR surface expression.
- CAR surface expression may impact CAR-T cell activation state.

## Abstract

Chimeric antigen receptor (CAR) T cells are a transformative treatment for hematological malignancies, and concerted efforts in the field are aiming to translate this success to solid tumors and autoimmune diseases. There is a desire in the field to accurately assess CAR organization and spatiotemporal expression to elucidate mechanistic details of CAR-T cell mediated anti-tumor activity and enable evaluation of the potency and safety of CAR-T cell products. We applied an IgG4-targeted F(ab)2 to achieve direct CAR labeling for super-resolution microscopy by direct stochastic optical reconstruction microscopy (dSTORM). This enabled us to determine CAR surface expression on human primary T cells with single-molecule resolution independent of CAR specificity. We combined this direct CAR detection approach with a phenotypic assessment of the CAR-T cells, highlighting prospective applications to gain detailed mechanistic insights. With this new approach, we were able to detect the surface expression of CARs targeting SLAMF7, BCMA and CD19 with minimal background. We determined T cell subtype, donor material, and CAR construct as contributing factors shaping CAR surface expression and identified putative influence of CAR surface expression on CAR-T cell activation state. Here we provide a novel, tag-free approach to gain insights into the surface expression of CARs, illustrating the potential of super-resolution microscopy to inform the application of synthetic immune receptors for CAR-T cell therapy, potentially building the basis for more intricate and combinatorial studies to further improve the efficacy of CAR-T cell immunotherapy, predict therapeutic outcome and ensure optimal care for patients.

## Linked entities

- **Proteins:** CASR (calcium sensing receptor), SLAMF7 (SLAM family member 7), TNFRSF17 (TNF receptor superfamily member 17), CD19 (CD19 molecule)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, TNFRSF17 (TNF receptor superfamily member 17) [NCBI Gene 608] {aka BCM, BCMA, CD269, TNFRSF13A}, SLAMF7 (SLAM family member 7) [NCBI Gene 57823] {aka 19A, CD319, CRACC, CS1}
- **Diseases:** autoimmune diseases (MESH:D001327), hematological malignancies (MESH:D019337), tumor (MESH:D009369)
- **Chemicals:** F(ab)2 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12354347/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12354347/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12354347/full.md

---
Source: https://tomesphere.com/paper/PMC12354347